Interline Therapeutics Funding: $92M Raised, Series A (2021)
Interline Therapeutics is based in South San Francisco. It has raised $92M in total funding. Latest round: Series A.
Interline Therapeutics funding overview
Interline Therapeutics is based in South San Francisco. Interline Therapeutics has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Interline Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Foresite Labs, ARCH Venture Partners. 2 distinct backers are named across the disclosed rounds.
Interline Therapeutics at a glance
Total raised
$92M
Latest round
Series A
Latest round date
May 2021
Headquarters
South San Francisco
Notable investors
Foresite Labs, ARCH Venture Partners
Frequently asked about Interline Therapeutics funding
How much has Interline Therapeutics raised?
Interline Therapeutics has raised $92M in total disclosed funding across the rounds on record.
Who has invested in Interline Therapeutics?
Foresite Labs, ARCH Venture Partners are named among the investors backing Interline Therapeutics.
What was the latest Interline Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2021.
Where is Interline Therapeutics based?
Interline Therapeutics is based in South San Francisco.
When did Interline Therapeutics last raise?
The last disclosed Interline Therapeutics round closed in May 2021 at Series A.
Interline Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in South San Francisco below to benchmark round size and investor mix.
